Company Directories & Business Directories
GLEIBERMAN, IRVING
Company Name: Corporate Name:
GLEIBERMAN, IRVING
Company Title:
Company Description:
Keywords to Search:
Company Address:
50 Mcintosh Dr #241,MARKHAM,ON,Canada
ZIP Code: Postal Code:
L3R9T3
Telephone Number:
9059405525
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):
811103
USA SIC Description:
Attorneys
Number of Employees:
1 to 4
Sales Amount:
Less than $500,000
Credit History:
Credit Report:
Very Good
Contact Person:
Irving Gleiberman
Remove my name
copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example , Blogger Example )
copy to clipboard
Company News:
GV1001 reduces neurodegeneration and prolongs lifespan in 3xTg . . . - PubMed We suggest that GV1001 exerts anti-ageing effects in 3xTg-AD mice by reducing neurodegeneration and senescence, which contributes to improved survival
GV1001 - ALZFORUM Originally developed as a cancer vaccine, GV1001 is a 16-amino-acid peptide comprising a sequence from the human enzyme telomerase reverse transcriptase (TERT) Most cancers highly express TERT, and immunization with GV1001 aims to activate the immune system to recognize and kill cancer cells
GV1001 Tertomotide,包含来自人类端粒酶逆转录酶(TERT)的序列 - 知乎 gv1001是一种16氨基酸肽,包含来自人类端粒酶逆转录酶(tert)的序列。 该肽可以穿透细胞,与HSP70和HSP90相互作用,并显示出不错的功效。 在普通细胞中,GV1001具有抗炎和抗氧化活性。
A novel telomerase-derived peptide GV1001-mediated inhibition of . . . GV1001, a human telomerase-derived 16-mer peptide, was provided by GemVax-KAEL (Seongnam, Republic of Korea)
GV1001 通过抗衰老作用减少 3xTg-AD 小鼠模型中的神经退行性变并延长寿命。,Aging-US - X-MOL 本研究旨在研究 GV1001 对三重转基因阿尔茨海默病 (3xTg-AD) 小鼠的神经退行性变、衰老和存活的影响。 将 GV1001 (1 mg kg) 皮下注射到老 3xTg-AD 小鼠中,每周三次,直至处死终点,并分析存活率。
这所院校又添新作:GV1001通过抗衰老作用减少3xTg-AD小鼠模型中的神经变性并延长寿命-论论 随着人口老龄化的加剧,老年人患上神经退行性疾病的情况也越来越普遍。然而,目前的治疗方法并不令人满意,因此有必要研究更有效的治疗方案。这篇论文旨在探讨gv1001对神经退行性疾病的保护作用,以及其延长寿命的机制。
潜在首款进行性核上性麻痹疗法GV1001在2a期临床试验中取得积极结果-上市-医保-临床适应症-香港济民药业 目前,gv1001已被研究用于治疗包括阿尔茨海默病和psp在内的神经退行性疾病。 在神经退行性疾病中,GV1001已被证明可以调节神经胶质细胞的表型,并调节神经炎症。
GV1001 modulates neuroinflammation and improves memory and behavior . . . Here, we investigated the protective effects and mechanism of action of GV1001 in triple transgenic AD (3xTg-AD) mice We found that GV1001 improved memory and cognition in middle- and old-aged 3xTg-AD mice
GV1001 modulates neuroinflammation and improves memory and behavior . . . GV1001 was injected subcutaneously into middle- and old-aged triple transgenic AD (3xTg-AD) mice according to the designated experimental schedules (Figs 1 A and 2 A, respectively)
GV1001 通过激活三重转基因阿尔茨海默病小鼠模型中的促性腺激素释放激素受体来调节神经炎症并改善记忆和行为,Brain, Behavior . . . 在体外研究中,gv1001 可保护神经细胞免受淀粉样蛋白-β (aβ) 毒性和其他应激源的影响,并在中度至重度阿尔茨海默病 (ad) 患者中表现出临床有益效果。在这里,我们研究了 gv1001 对三重转基因 ad (3xtg-ad) 小鼠的保护作用和作用机制。